MedPath

Sumitomo Dainippon Pharma Co., Ltd.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

147

Active:4
Completed:44

Trial Phases

5 Phases

Phase 1:34
Phase 2:31
Phase 3:62
+2 more phases

Drug Approvals

3

NMPA:3

Drug Approvals

Blonanserin Tablets

Product Name
洛珊
Approval Number
国药准字HJ20170060
Approval Date
Sep 18, 2021
NMPA

Blonanserin Tablets

Product Name
洛珊
Approval Number
国药准字HJ20170059
Approval Date
Sep 18, 2021
NMPA

Tandospirone Citrate Tablets

Product Name
枸橼酸坦度螺酮片
Approval Number
H20140654
Approval Date
Aug 27, 2014
NMPA

Clinical Trials

Distribution across different clinical trial phases (145 trials with phase data)• Click on a phase to view related trials

Phase 3
62 (42.8%)
Phase 1
34 (23.4%)
Phase 2
31 (21.4%)
Not Applicable
9 (6.2%)
Phase 4
6 (4.1%)
phase_1_2
2 (1.4%)
phase_2_3
1 (0.7%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.